Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. (Q52026782)

20 April 2018

title

Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. (English)

1 reference

20 April 2018

0 references

1 reference

multi-infarct dementia

1 reference

Pantoni L

1

1 reference

20 April 2018

Rossi R

2

1 reference

20 April 2018

Inzitari D

3

1 reference

20 April 2018

Bianchi C

4

1 reference

20 April 2018

Beneke M

5

1 reference

20 April 2018

Erkinjuntti T

6

1 reference

20 April 2018

Wallin A

7

1 reference

20 April 2018

publication date

1 April 2000

1 reference

20 April 2018

Journal of the Neurological Sciences

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 April 2018

volume

175

1 reference

20 April 2018

issue

2

1 reference

20 April 2018

page(s)

124-134

1 reference

20 April 2018

Heterogeneity of vascular dementia: mechanisms and subgroups

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Classification, diagnosis and treatment of vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Types of multi-infarct dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Senile dementia of the Binswanger type. A vascular form of dementia in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Pathogenesis of leukoaraiosis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Human pial vascular reactions to intravenous Nimodipine-infusion during EC-IC bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Effects of calcium antagonists on intracerebral penetrating arterioles in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Formation of cerebrovascular anomalies in the ageing rat is delayed by chronic nimodipine application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Nimodipine effects on cerebral microvessels and sciatic nerve in aging rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Vascular pathology in three cases of progressive cognitive deterioration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

CT in the differential diagnosis between Alzheimer's disease and vascular dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Psychometrics in aging and dementia: advances in geropsychological assessments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Cerebral blood flow in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

A new rating scale for dementia syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

A rapid disability rating scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

A new clinical scale for the staging of dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Guaranteed stimulus-processing in the evaluation of memory and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Patterns of performance on the Fuld Object Memory Evaluation in elderly inpatients with depression or dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Normative data for eight neuropsychological tests based on a Danish sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Word-list generation deficits in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

The syndrome of normal-pressure hydrocephalus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

The Measurement of Observer Agreement for Categorical Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Vascular dementia: neuropathologic alterations and metabolic brain changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Why do frontal lobe symptoms predominate in vascular dementia with lacunes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Frontal-subcortical circuits and human behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Relationship between vascular factors and white matter low attenuation of the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Neuropathological assessment of the lesions of significance in vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

Clinical evaluation of the ICD-10 criteria for vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900300-2

10.1016/S0022-510X(00)00300-2

7 January 2021

Identifiers

DOI

1 reference

20 April 2018

release_ujnoiuufhveghh46g4pbg6fcdm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ujnoiuufhveghh46g4pbg6fcdm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10831773

1 reference

20 April 2018